ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 917

$1.14M Total Retail Price of All Prescriptions

Rank: 11 out of 917

661 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 661 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 661 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 15,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 902 832 1 2
OMEPRAZOLE 672 622 2 4
LEVOTHYROXINE SODIUM 549 499 3 3
LISINOPRIL 521 467 4 1
FUROSEMIDE 506 481 5 7
WARFARIN SODIUM 485 470 6 10
AMLODIPINE BESYLATE 368 325 7 5
DONEPEZIL HCL 353 353 8 32
METOPROLOL SUCCINATE 292 287 9 18
CARVEDILOL 289 254 10 33
PRAVASTATIN SODIUM 275 251 11 20
SERTRALINE HCL 274 272 12 24
LOSARTAN POTASSIUM 268 245 13 13
CITALOPRAM HBR 256 248 14 15
METOPROLOL TARTRATE 253 231 15 11
POTASSIUM CHLORIDE 239 229 16 16
ACTOS 235 194 17 112
HYDROCODONE-ACETAMINOPHEN 235 219 S3 17 6
TAMSULOSIN HCL 227 226 19 25
NAMENDA 220 220 20 43
ATORVASTATIN CALCIUM 213 191 21 14
CRESTOR 211 199 22 30
ZOLPIDEM TARTRATE 202 199 23 21
JANUVIA 202 184 23 81
LANTUS SOLOSTAR 190 183 25 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 149 26 42
METFORMIN HCL 165 134 27 8
FLUOXETINE HCL 158 151 28 38
HYDROCHLOROTHIAZIDE 158 151 28 9
RISPERIDONE 156 156 30 51
FENTANYL 152 137 S2 31 58
MIRTAZAPINE 151 151 32 39
TRAZODONE HCL 142 124 33 22
OXYCODONE HCL 142 79 S2 33 27
METHADONE HCL 136 116 S2 35 59
GABAPENTIN 128 87 36 17
VENLAFAXINE HCL ER 124 97 37 78
BENAZEPRIL HCL 124 116 37 80
FENOFIBRATE 123 90 39 73
LYRICA 119 111 40 122
CLOPIDOGREL 117 115 41 50
PIOGLITAZONE HCL 116 96 R 42 248
SPIRONOLACTONE 107 107 43 55
MORPHINE SULFATE ER 104 98 S2 44 48
CYMBALTA 104 86 44 56
MELOXICAM 102 95 46 53
LANTUS 100 88 47 37
ALLOPURINOL 99 81 48 31
LOSARTAN-HYDROCHLOROTHIAZIDE 93 92 49 62
FLUTICASONE PROPIONATE 92 73 50 26
DIGOXIN 90 88 51 41
POLYETHYLENE GLYCOL 3350 88 84 52 66
PREDNISONE 86 80 53 34
SPIRIVA 85 85 54 45
FINASTERIDE 82 82 55 77
RANITIDINE HCL 81 60 56 29
CEPHALEXIN 77 73 57 105
NOVOLOG FLEXPEN 77 63 57 132
TRIAMTERENE-HCTZ 77 62 57 36
LOVASTATIN 75 69 60 19
AMITRIPTYLINE HCL 74 38 R 61 67
CIPROFLOXACIN HCL 73 53 62 72
PEN NEEDLE 72 70 63 99
ADVAIR DISKUS 68 62 64 47
PAROXETINE HCL 66 41 65 57
CARBIDOPA-LEVODOPA 65 65 66 86
ALENDRONATE SODIUM 62 57 67 23
PANTOPRAZOLE SODIUM 62 49 67 44
EXELON 62 62 67 207
QUETIAPINE FUMARATE 61 58 70 52
OXYCODONE-ACETAMINOPHEN 61 39 S2 70 46
VESICARE 61 57 70 166
PREMARIN 60 60 R 73 146
NEXIUM 58 58 74 60
GALANTAMINE HBR 57 57 75 222
PRAMIPEXOLE DIHYDROCHLORIDE 56 53 76 137
ESCITALOPRAM OXALATE 54 54 77 114
QUINAPRIL HCL 53 45 78 278
ATENOLOL 53 53 78 12
ROPINIROLE HCL 53 46 78 88
DILTIAZEM ER 52 52 81 106
BENAZEPRIL-HYDROCHLOROTHIAZIDE 51 51 82 247
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.